Use of Non Biologic DMARD in Rheumatoid Arthritis with Emphasis on Leflunomide

Journal Title: Journal of Medical Science And clinical Research - Year 2017, Vol 5, Issue 7

Abstract

Background: Being the commonest rheumatoligical disease the treatment of rheumatoid arthritis requires optimisation. The use of disease modifying medications in rheumatoid arthritis needs particular emphasis. Many patients presents late with deformities resulting in significant morbidity. Methods: We conducted a prospective study involving 60 patients with active rheumatoid arthritis and a double blind comparison sub study in which outcome of treatment of 35 patients were analysed between methotrexate and leflunomide. Results: The 60 patients studied were predominantly women (mean age, 52 years; mean disease duration, 4.5 years) The ACR response for patients receiving leflunomide treatment was 52% and that of methotrexate treatment was 48%. They were statistically equivalent, with mean time to initial response at 8.2 weeks for patients receiving leflunomide vs 9.1 weeks for patients receiving methotrexate therapy. X-ray analyses demonstrated less disease progression with both arms of the study. Common adverse events for patients receiving leflunomide treatment included gastrointestinal complaints, skin rash, and reversible alopecia. Conclusions: Current treatments for rheumatoid arthritis (RA) include nonsteroidal anti-inflammatory drugs (NSAIDs), low-dose steroids, and disease-modifying antirheumatic drugs (DMARDs). No currently available medication is uniformly effective, and all may cause significant adverse effects. The active control drug for this study, methotrexate, is considered to be the "gold standard" DMARD for the treatment of RA. Clinical responses following administration of leflunomide, a relatively new therapeutic agent for the treatment of RA, were statistically equivalent to those with methotrexate treatment. Both treatments improved signs and symptoms of active RA, delayed disease progression as demonstrated by x-ray films, and improved function and health-related quality of life.

Authors and Affiliations

Ajith S. N

Keywords

Related Articles

Study of Clinico-pathological Spectrum of Lymphadenopathy

Introduction: Inflammation or enlargement of lymph nodes has clinical significance because it occurs in various diseases ranges from throat infections to life threatening cancers. The lymph node involvement has an import...

Proline mesh hernioplasty of inguinal hernia: under general versus local anaesthesia

Background: Repair of Inguinal hernia is one of the most common surgical procedures that can be performed under general, spinal or local anesthesia. Selection of type of anaesthesia depends on different factors. There ha...

Clinico-demographic profile of children of age 1-5 years with Malnutrition in Kishanganj district, Bihar

Introduction: Malnourished children, especially in rural area fail to ahieve their full developmental potential. Objective: To study the clinico-demographic profile of children with malnutrition in Kishanganj district, B...

Down Syndrome– Correlation of Head Circumference, Weight and Height

Aim: The study aimed to find the difference in the head circumference of both male and female Down syndrome cases. Objectives: The main objective of the study is to assess the correlation between the height, weight and h...

Clinicopathological Profile of Metastatic Cervical Lymph Nodes- A Descriptive Study in a Tertiary Care Centre

The single most important factor determining the survival of patients with head and neck malignancy is the presence or absence of metastatic disease in the neck. clinicopathological profile of metastatic lymph nodes were...

Download PDF file
  • EP ID EP527266
  • DOI -
  • Views 96
  • Downloads 0

How To Cite

Ajith S. N (2017). Use of Non Biologic DMARD in Rheumatoid Arthritis with Emphasis on Leflunomide. Journal of Medical Science And clinical Research, 5(7), 25330-25341. https://europub.co.uk/articles/-A-527266